Vibrio cholerae Evades Neutrophil Extracellular Traps by the Activity of Two Extracellular Nucleases

PLoS Pathogens

Volumn 9, Issue 9, 2013, Pages

  Seper, Andrea ^a   Hosseinzadeh, Ava ^b   Gorkiewicz, Gregor ^c   Lichtenegger, Sabine ^a   Roier, Sandro ^a   Leitner, Deborah R ^a   Röhm, Marc ^b   Grutsch, Andreas ^a   Reidl, Joachim ^a   Urban, Constantin F ^b   Schild, Stefan ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b UMEÅ UNIVERSITY   (Sweden)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; DNA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; NUCLEASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIUM MUTANT; CHOLERA; CONTROLLED STUDY; DEGRADATION; EXTRACELLULAR SPACE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MOUSE; NEUTROPENIA; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIBRIO CHOLERAE;

ANIMALS; BACTERIAL PROTEINS; CHOLERA; DEOXYRIBONUCLEASES; FEMALE; HUMANS; IMMUNITY, INNATE; MALE; MICE; MICE, KNOCKOUT; MICROBIAL VIABILITY; NEUTROPHILS; VIBRIO CHOLERAE;

EID: 84884679672     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003614     Document Type: Article

References (68)

1. WHO (2012) Cholera annual report 2011. Weekly epidemiological record 87: 289-304.
2. (CDC) CfDCaP (2010) Cholera outbreak - Haiti, October 2010. MMWR Morb Mortal Wkly Rep 59: 1411.
3. Yildiz FH, Visick KL, (2009) Vibrio biofilms: so much the same yet so different. Trends Microbiol 17: 109-118.
4. Colwell RR, (2000) Viable but nonculturable bacteria: a survival strategy. J Infect Chemother 6: 121-125.
5. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB, (2012) Cholera. Lancet 379: 2466-2476.
6. Sack DA, Sack RB, Nair GB, Siddique AK, (2004) Cholera. Lancet 363: 223-233.
7. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, et al. (2002) Host-induced epidemic spread of the cholera bacterium. Nature 417: 642-645.
8. Nelson EJ, Harris JB, Morris JG Jr, Calderwood SB, Camilli A, (2009) Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol 7: 693-702.
9. Mathan MM, Chandy G, Mathan VI, (1995) Ultrastructural changes in the upper small intestinal mucosa in patients with cholera. Gastroenterology 109: 422-430.
10. Qadri F, Bhuiyan TR, Dutta KK, Raqib R, Alam MS, et al. (2004) Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Gut 53: 62-69.
11. Bandyopadhaya A, Sarkar M, Chaudhuri K, (2007) Transcriptional upregulation of inflammatory cytokines in human intestinal epithelial cells following Vibrio cholerae infection. Febs J 274: 4631-4642.
12. Flach CF, Qadri F, Bhuiyan TR, Alam NH, Jennische E, et al. (2007) Broad up-regulation of innate defense factors during acute cholera. Infect Immun 75: 2343-2350.
13. Goo SY, Han YS, Kim WH, Lee KH, Park SJ, (2007) Vibrio vulnificus IlpA-induced cytokine production is mediated by Toll-like receptor 2. J Biol Chem 282: 27647-27658.
14. Haines GK, (2005) Role of toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El tor strains deficient in production of cholera toxin and accessory toxins. Infect Immun 73: 6157-6164.
15. Harrison LM, Rallabhandi P, Michalski J, Zhou X, Steyert SR, et al. (2008) Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation. Infect Immun 76: 5524-5534.
16. Burkart V, Kim YE, Hartmann B, Ghiea I, Syldath U, et al. (2002) Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide. J Immunol 168: 1730-1737.
17. Levine MM, Kaper JB, Herrington D, Losonsky G, Morris JG, et al. (1988) Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun 56: 161-167.
18. Ryan ET, Calderwood SB, Qadri F, (2006) Live attenuated oral cholera vaccines. Expert Rev Vaccines 5: 483-494.
19. Queen J, Satchell KJ, (2012) Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection. Infect Immun 80: 2905-2913.
20. Olivier V, Salzman NH, Satchell KJ, (2007) Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins. Infect Immun 75: 5043-5051.
21. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
22. Papayannopoulos V, Zychlinsky A, (2009) NETs: a new strategy for using old weapons. Trends Immunol 30: 513-521.
23. Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, et al. (2006) DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 16: 396-400.
24. Berends ET, Horswill AR, Haste NM, Monestier M, Nizet V, et al. (2010) Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J Innate Immun 2: 576-586.
25. Beiter K, Wartha F, Albiger B, Normark S, Zychlinsky A, et al. (2006) An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr Biol 16: 401-407.
26. Schild S, Tamayo R, Nelson EJ, Qadri F, Calderwood SB, et al. (2007) Genes induced late in infection increase fitness of Vibrio cholerae after release into the environment. Cell Host Microbe 2: 264-277.
27. Seper A, Fengler VH, Roier S, Wolinski H, Kohlwein SD, et al. (2011) Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation. Mol Microbiol 82: 1015-1037.
28. Nygren E, Li BL, Holmgren J, Attridge SR, (2009) Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae. Infect Immun 77: 3475-3484.
29. Chelvarajan RL, Collins SM, Doubinskaia IE, Goes S, Van Willigen J, et al. (2004) Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J Leukoc Biol 75: 982-994.
30. Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, et al. (2006) Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol 79: 1314-1327.
31. Bogaert D, Weinberger D, Thompson C, Lipsitch M, Malley R, (2009) Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model. Infect Immun 77: 1613-1622.
32. Olivier V, Queen J, Satchell KJ, (2009) Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins. PLoS One 4: e7352.
33. Hofbauer R, Moser D, Hammerschmidt V, Kapiotis S, Frass M, (1998) Ketamine significantly reduces the migration of leukocytes through endothelial cell monolayers. Crit Care Med 26: 1545-1549.
34. Zilberstein G, Levy R, Rachinsky M, Fisher A, Greemberg L, et al. (2002) Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth Analg 95: 531-536 table of contents.
35. Weigand MA, Schmidt H, Zhao Q, Plaschke K, Martin E, et al. (2000) Ketamine modulates the stimulated adhesion molecule expression on human neutrophils in vitro. Anesth Analg 90: 206-212.
36. Zahler S, Heindl B, Becker BF, (1999) Ketamine does not inhibit inflammatory responses of cultured human endothelial cells but reduces chemotactic activation of neutrophils. Acta Anaesthesiol Scand 43: 1011-1016.
37. Bischoff DS, Zhu JH, Makhijani NS, Yamaguchi DT, (2005) KC chemokine expression by TGF-beta in C3H10T1/2 cells induced towards osteoblasts. Biochem Biophys Res Commun 326: 364-370.
38. Li Q, Park PW, Wilson CL, Parks WC, (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111: 635-646.
39. Frevert CW, Huang S, Danaee H, Paulauskis JD, Kobzik L, (1995) Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol 154: 335-344.
40. Huang S, Paulauskis JD, Godleski JJ, Kobzik L, (1992) Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 141: 981-988.
41. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, et al. (1989) Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci U S A 86: 612-616.
42. Kobayashi Y, (2008) The role of chemokines in neutrophil biology. Front Biosci 13: 2400-2407.
43. Qadri F, Raqib R, Ahmed F, Rahman T, Wenneras C, et al. (2002) Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin Diagn Lab Immunol 9: 221-229.
44. Das T, Mukherjee S, Chaudhuri K, (2012) Effect of quercetin on Vibrio cholerae induced nuclear factor-kappaB activation and interleukin-8 expression in intestinal epithelial cells. Microbes Infect 14: 690-695.
45. Ermert D, Urban CF, Laube B, Goosmann C, Zychlinsky A, et al. (2009) Mouse neutrophil extracellular traps in microbial infections. J Innate Immun 1: 181-193.
46. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE, (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83: 64-70.
47. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, et al. (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176: 231-241.
48. Valeva A, Walev I, Weis S, Boukhallouk F, Wassenaar TM, et al. (2008) Pro-inflammatory feedback activation cycle evoked by attack of Vibrio cholerae cytolysin on human neutrophil granulocytes. Med Microbiol Immunol 197: 285-293.
49. Hosseinzadeh A, Messer PK, Urban CF, (2012) Stable Redox-Cycling Nitroxide Tempol Inhibits NET Formation. Front Immunol 3: 391.
50. Broz P, Ohlson MB, Monack DM, (2012) Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes 3: 62-70.
51. Cover TL, Aber RC, (1989) Yersinia enterocolitica. N Engl J Med 321: 16-24.
52. Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, et al. (1997) Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 186: 739-747.
53. Bennouna S, Bliss SK, Curiel TJ, Denkers EY, (2003) Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J Immunol 171: 6052-6058.
54. Urban CF, Reichard U, Brinkmann V, Zychlinsky A, (2006) Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol 8: 668-676.
55. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, et al. (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15: 623-625.
56. Braun MC, He J, Wu CY, Kelsall BL, (1999) Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J Exp Med 189: 541-552.
57. Fullner KJ, Boucher JC, Hanes MA, Haines GK, (2002) The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J Exp Med 195: 1455-1462.
58. Uchiyama S, Andreoni F, Schuepbach RA, Nizet V, Zinkernagel AS, (2012) DNase Sda1 allows invasive M1T1 Group A Streptococcus to prevent TLR9-dependent recognition. PLoS Pathog 8: e1002736.
59. Altermark B, Niiranen L, Willassen NP, Smalas AO, Moe E, (2007) Comparative studies of endonuclease I from cold-adapted Vibrio salmonicida and mesophilic Vibrio cholerae. Febs J 274: 252-263.
60. Blokesch M, (2008) Schoolnik GK (2008) The extracellular nuclease Dns and its role in natural transformation of Vibrio cholerae. J Bacteriol 190: 7232-7240.
61. Miller VL, DiRita VJ, Mekalanos JJ, (1989) Identification of toxS, a regulatory gene whose product enhances toxR-mediated activation of the cholera toxin promoter. J Bacteriol 171: 1288-1293.
62. Ray A, Dittel BN, (2010) Isolation of mouse peritoneal cavity cells. J Vis Exp 35: 1488.
63. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
64. Young RL, Malcolm KC, Kret JE, Caceres SM, Poch KR, et al. (2012) Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. PLoS One 6: e23637.
65. Menegazzi R, Decleva E, Dri P, (2012) Killing by neutrophil extracellular traps: fact or folklore? Blood 119: 1214-1216.
66. Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, et al. (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5: e1000639.
67. Hankins JV, Madsen JA, Giles DK, Childers BM, Klose KE, et al. (2011) Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition. Mol Microbiol 81: 1313-1329.
68. Leitner DR, Feichter S, Schild-Prufert K, Rechberger GN, Reidl J, et al. (2013) Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen. Infect Immun 81: 2379-2393.